Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Melanoma × adavosertib × Clear all

Sponsor

Conditions

Uterine Cervical Neoplasms 2 Solid Tumors 2 Ovarian Neoplasms 2 Neoplasms 2 Lung Neoplasms 2 Advanced Malignant Solid Neoplasm 2 Vaginal Neoplasms 1 Triple-negative Metastatic Breast Cancer 1 Triple Negative Breast Neoplasms 1 Tongue Neoplasms 1 Stomach Neoplasms 1 Squamous Cell Carcinoma of Head and Neck 1 Rhabdomyosarcoma 1 Previously Treated Non Small Cell Lung Cancer 1 Platinum Refractory Extensive-Stage Small Cell Lung Carcinoma 1 Pinealoma 1 Ovarian, Fallopian Tube, Peritoneal Cancer, P53 Mutation 1 Neuroectodermal Tumors, Primitive 1 Neuroblastoma 1 Neoplasm Metastasis 1 Myelodysplastic-Myeloproliferative Diseases 1 Metastatic Pancreatic Adenocarcinoma 1 Meningeal Carcinomatosis 1 Medulloblastoma 1 Lymphoid Interstitial Pneumonia 1 Leukemia, Myelomonocytic, Chronic 1 Leukemia, Myeloid, Acute 1 Head and Neck Neoplasms 1 Gliosarcoma 1 Glioblastoma 1

Interventions

Ipilimumab 96 pembrolizumab 81 Nivolumab 79 aldesleukin 51 Cyclophosphamide 49 Interleukin-2 38 fludarabine phosphate 31 Vemurafenib 31 Dacarbazine 31 dabrafenib 29 trametinib 28 Temozolomide 26 fludarabine 25 CTLA-4 Antigen 18 Bevacizumab 18 Radiosurgery 15 Paclitaxel 15 Carboplatin 14 encorafenib 13 binimetinib 13 Introns 13 talimogene laherparepvec 12 Interferon alpha-2 12 spartalizumab 10 cobimetinib 10 atezolizumab 10 Radiotherapy 10 sargramostim 9 peginterferon alfa-2b 9 montanide ISA 51 9

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡